These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 9216695)
21. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach. Kim HS; Hong EK; Park SY; Kim WH; Lee HS Anticancer Res; 2003; 23(3C):2863-8. PubMed ID: 12926124 [TBL] [Abstract][Full Text] [Related]
22. Relation of E-cadherin and beta-catenin expression to pit pattern in colorectal cancer. Kojima M; Shiokawa A; Ohike N; Tamegai Y; Kato H; Morohoshi T Oncol Rep; 2004 Sep; 12(3):533-8. PubMed ID: 15289833 [TBL] [Abstract][Full Text] [Related]
24. Expression of E-cadherin and catenins in invasive mammary carcinomas. Zschiesche W; Schönborn I; Behrens J; Herrenknecht K; Hartveit F; Lilleng P; Birchmeier W Anticancer Res; 1997; 17(1B):561-7. PubMed ID: 9066580 [TBL] [Abstract][Full Text] [Related]
25. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. Bagutti C; Speight PM; Watt FM J Pathol; 1998 Sep; 186(1):8-16. PubMed ID: 9875134 [TBL] [Abstract][Full Text] [Related]
26. Beta- and gamma-catenin expression in oral squamous cell carcinomas. Lo Muzio L; Staibano S; Pannone G; Grieco M; Mignogna MD; Cerrato A; Testa NF; De Rosa G Anticancer Res; 1999; 19(5B):3817-26. PubMed ID: 10628318 [TBL] [Abstract][Full Text] [Related]
27. Expression of classic cadherins type I in urothelial neoplastic progression. Rieger-Christ KM; Cain JW; Braasch JW; Dugan JM; Silverman ML; Bouyounes B; Libertino JA; Summerhayes IC Hum Pathol; 2001 Jan; 32(1):18-23. PubMed ID: 11172290 [TBL] [Abstract][Full Text] [Related]
28. Expression of E-cadherin and beta-catenin in the adenoma-carcinoma sequence of ampulla of Vater cancer. Park S; Kim SW; Lee BL; Jung EJ; Kim WH Hepatogastroenterology; 2006; 53(67):28-32. PubMed ID: 16506371 [TBL] [Abstract][Full Text] [Related]
29. Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers. Aust DE; Terdiman JP; Willenbucher RF; Chew K; Ferrell L; Florendo C; Molinaro-Clark A; Baretton GB; Löhrs U; Waldman FM Mod Pathol; 2001 Jan; 14(1):29-39. PubMed ID: 11211307 [TBL] [Abstract][Full Text] [Related]
30. Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex. Rocha AS; Soares P; Machado JC; Máximo V; Fonseca E; Franssila K; Sobrinho-Simões M Virchows Arch; 2002 May; 440(5):498-504. PubMed ID: 12021924 [TBL] [Abstract][Full Text] [Related]
31. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer. Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116 [TBL] [Abstract][Full Text] [Related]
32. E-cadherin and catenins: molecules with versatile roles in normal and neoplastic epithelial cell biology. El-Bahrawy MA; Pignatelli M Microsc Res Tech; 1998 Nov; 43(3):224-32. PubMed ID: 9840800 [TBL] [Abstract][Full Text] [Related]
33. N-cadherin-catenin interaction: necessary component of cardiac cell compartmentalization during early vertebrate heart development. Linask KK; Knudsen KA; Gui YH Dev Biol; 1997 May; 185(2):148-64. PubMed ID: 9187080 [TBL] [Abstract][Full Text] [Related]
34. Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines. Noda M; Tatsumi Y; Tomizawa M; Takama T; Mitsufuji S; Sugihara H; Kashima K; Hattori T J Gastroenterol; 2002; 37(11):896-904. PubMed ID: 12483244 [TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors. Marques FR; Fonsechi-Carvasan GA; De Angelo Andrade LA; Böttcher-Luiz F Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114 [TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression. Shih HC; Shiozawa T; Miyamoto T; Kashima H; Feng YZ; Kurai M; Konishi I Anticancer Res; 2004; 24(6):3843-50. PubMed ID: 15736420 [TBL] [Abstract][Full Text] [Related]
37. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas. Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359 [TBL] [Abstract][Full Text] [Related]
38. Cadherin-catenin expression in primary colorectal cancer: a survival analysis. Hugh TJ; Dillon SA; Taylor BA; Pignatelli M; Poston GJ; Kinsella AR Br J Cancer; 1999 Jun; 80(7):1046-51. PubMed ID: 10362114 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma. Hori H; Fujimori T; Fujii S; Ichikawa K; Ohkura Y; Tomita S; Ono Y; Imura J; Kuroda Y Dis Colon Rectum; 2005 May; 48(5):938-45. PubMed ID: 15785891 [TBL] [Abstract][Full Text] [Related]
40. Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]. Bukholm IK; Nesland JM; Børresen-Dale AL J Pathol; 2000 Jan; 190(1):15-9. PubMed ID: 10640987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]